Clinical Trial Update: The Effect of Midazolam on Fluid Responsiveness in Septic Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating whether midazolam affects fluid responsiveness in septic shock patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: Southeast University, China | Conditions: Septic Shock | Phase 1, Phase 2 | Status: COMPLETED